Harmony Biosciences Holdings (HRMY) Earnings Date & Reports
Get AI intraday signals
A.I. Advisor
published Earnings
HRMY is expected to report earnings to fall 34.29% to 68 cents per share on October 29
Q3'24
Est.
$0.69
Q2'24
Beat
by $1.04
Q1'24
Beat
by $0.25
Q4'23
Beat
by $0.01
Q3'23
Beat
by $0.30
The last earnings report on August 06 showed earnings per share of $1.05, beating the estimate of 0 cents. With 397.17K shares outstanding, the current market capitalization sits at 2.22B.
a commercial-stage pharmaceutical company, which engages in the development and commercialization of therapies for the treatment of neurological disorders